All Crowdz
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Offres
  • Emplois
  • Courses
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Aarya Jain Ajouter une nouvelle offre d'emploi Networking
    2025-10-29 13:06:26 -
    Digital Integration Reshaping the Future of the Thalassemia Market
    Market Overview The global Thalassemia market was valued at USD 752.3 million in 2021 and is expected to grow at a CAGR of 8.2% during the forecast period.  Thalassemia is a group of inherited blood disorders characterized by reduced or absent production of normal hemoglobin chains. It includes alpha- and beta-thalassemia and ranges from asymptomatic carrier states to severe...
    0 Commentaires 0 Parts 164 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Sanket Khot Ajouter une nouvelle offre d'emploi Health
    2025-11-19 19:35:02 -
    Thalassemia Market Outlook: Growth, Trends, Size, and Segmentation Insights
    Executive Summary Thalassemia Market Opportunities by Size and Share Thalassemia Market Size The Global thalassemia market size was valued at USD 986.00 million in 2024 and is projected to reach USD 3,232.52 million by 2032, with a CAGR of 16.00% during the forecast period of 2025 to 2032. An international Thalassemia Market report lends a hand to identify how the market is going to...
    0 Commentaires 0 Parts 17 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Reifide Simere Ajouter une nouvelle offre d'emploi Health
    2025-10-28 04:47:32 -
    The Urgency for Curative Solutions: Analyzing Alpha Thalassemia Market Demands for Gene Therapy and Novel Drug Classes
      The fundamental Alpha Thalassemia Market Demands are being driven by a profound and urgent need to move beyond lifelong, symptomatic management, which currently relies heavily on chronic blood transfusions and iron chelation therapy. The primary demand driver is the requirement for curative therapies. Patients, caregivers, and clinicians are highly receptive to novel genetic and...
    0 Commentaires 0 Parts 135 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2025 All Crowdz French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire